An interventional study of transcranial direct current stimulation and Physical exercise in Chronic Pain, sponsored by Université de Sherbrooke. Recruiting at 2 sites in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-03-27.
Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Chronic Pain by Université de Sherbrooke — 8 open to participants now, 9 under way, none of them phase 3. Chronic Pain · Université de Sherbrooke.
Among the 15 studies in Chronic Pain by Université de Sherbrooke, this one is the 6th largest by planned enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2020, is one of 10 with no phase, and was the 5th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →8 of the 15 studies in Chronic Pain by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:
Université de Sherbrooke · Sites in Canada
Ages 18+
Université de Sherbrooke · Sites in Canada
Ages 65+
Université de Sherbrooke · Sites in Canada
Ages 55+
Université de Sherbrooke · Sites in Canada
Ages 56+
Université de Sherbrooke · Sites in Canada
Ages 18+
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 60 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 32 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 32 across the 11 interventional studies, 137 across the 4 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Université de Sherbrooke is the lead sponsor of 298 studies on the registry; 67 are open to participants now.
1 of the studies in Chronic Pain by Université de Sherbrooke that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07137845Université de SherbrookeVirtual Reality and Cranial Nerve Non-invasive Neuromodulation to Improve Quality of Life for Veterans | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Chronic Pain by Université de Sherbrooke, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to relieve pain. For those patients, adding an exogenous stimulation of the motor system such as transcranial direct current stimulation (tDCS) would facilitate the corticospinal tract, and consequently, would help exercises to relieve chronic pain. The investigators hypothesize that combining tDCS with the exercises will be more effective than exercises alone, but only in individuals who initially show low corticospinal projections.
Prevalence and intensity of chronic pain increases substantially with age. According to several studies, physical exercises are effective to reduce chronic pain in elderly. However, it seems that exercises are not effective for everyone. One of the hypotheses raised is that the people in whom the exercises have no effect would be those with an alteration of the corticospinal tract. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique known to facilitate the corticospinal tract when applied over the motor cortex.
Elderly suffering from chronic pain will be recruited in this double-blind, parallel-group, randomised control trial. Participants will be randomized to receive exercises combined to real tDCS (5 daily sessions, 2 mA, 20 minutes) or to sham tDCS. Intervention will last 8 weeks at a rate of 3 workouts per week.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week. For the first week, participants will receive 5 daily sessions of anodal tDCS (2 mA, 20 min).
Other: transcranial direct current stimulation · Other: Physical exercise
Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week. For the first week, participants will receive 5 daily sessions of sham tDCS.
Other: Physical exercise
real tDCS sessions
Aerobic exercise and physical training combined with sham tDCS
Changes in Pain intensity
Pain intensity will be assessed with a pain logbook containing a numerical rating scale from 0 to 10
Time frame: Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)
Corticospinal excitability (TMS)
Corticospinal tract excitability will be assessed with transcranial magnetic stimulation (TMS)
Time frame: Before intervention, Follow-up 1 week after, Follow-up 1 month after
Corticospinal excitability (dMRI)
Corticospinal tract excitability will be assessed diffusion magnetic resonance imaging
Time frame: Before intervention, Follow-up 1 week after, Follow-up 1 month after
Functional connectivity
Functional connectivity will be assessed with functional magnetic resonance imaging
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
McGill pain questionnaire
McGill pain questionnaire will be used to assess pain in its globality. Score from 0 to 72, higher score means worse outcome.
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Brief pain inventory
Brief pain inventory will be used to assess pain in its globality. Score from 0 to 70, higher score means worse outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Beck depression inventory
Beck depression inventory will be used to assess pain in its globality. Score from 0 to 39, higher score means worse outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Beck anxiety inventory
Beck anxiety inventory will be used to assess pain in its globality. Score from 0 to 63, higher score means worse outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Margolis pain drawing and scoring system
Margolis pain drawing and scoring system will be used to assess pain in its globality. Score from 0 to 45, higher score means worse outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Patient global impression of change questionnaire
patient global impression of change questionnaire will be used to assess pain in its globality. Score from 0 to 18 and a percentage from 0 to 100. Higher scores mean better outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Tampa questionnaire
Tampa questionnaire will be used to assess pain in its globality. Score from 0 to 68, higher score means worse outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Pain catastrophizing scale
Pain catastrophizing scale will be used to assess pain in its globality. Score from 0 to 52, higher score means worse outcome
Time frame: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2020 (actual). Primary completion is estimated for Oct 2023, 34 months after the start.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 34 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.